A micro RNA-146a polymorphism is associated with coronary restenosis

International Journal of Immunogenetics

Volumn 41, Issue 5, 2014, Pages 393-396

  Hamann, L ^a   Glaeser, C ^b   Schulz, S ^b   Gross, M ^a   Franke, A ^c   Nothlings U ^d   Schumann, R R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN146 MICRORNA, HUMAN;

ADULT; AGED; ALLELE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; RESTENOSIS; RISK;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 84908373062     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/iji.12136     Document Type: Article

References (17)

1. Azar, R.R., McKay, R.G., Kiernan, F.J., Seecharran, B., Feng, Y.J., Fram, D.B. et al. (1997) Coronary angioplasty induces a systemic inflammatory response. American Journal of Cardiology, 80, 1476.
2. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281.
3. Bennermo, M., Held, C., Stemme, S., Ericsson, C.G., Silveira, A., Green, F. et al. (2004) Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clinical Chemistry, 50, 2136.
4. Chen, S., Sorrentino, R., Shimada, K., Bulut, Y., Doherty, T.M., Crother, T.R. et al. (2008) Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. The Journal of Immunology, 181, 7186.
5. Hamann, L., Gomma, A., Schroder, N.W., Stamme, C., Glaeser, C., Schulz, S. et al. (2005) A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. Journal of Molecular Medicine, 83, 478.
6. Jazdzewski, K., Liyanarachchi, S., Swierniak, M., Pachucki, J., Ringel, M.D., Jarzab, B. et al. (2009) Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proceedings of the National Academy of Sciences of the USA, 106, 1502.
7. Kovacs, A., Green, F., Hansson, L.O., Lundman, P., Samnegard, A., Boquist, S. et al. (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis, 178, 193.
8. Michelsen, K.S. & Arditi, M. (2006) Toll-like receptor signaling and atherosclerosis. Current Opinion in Hematology, 13, 163.
9. O'Neill, L.A. & Bowie, A.G. (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology, 7, 353.
10. Ramkaran, P., Khan, S., Phulukdaree, A., Moodley, D. & Chuturgoon, A. (2014) miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochemistry and Biophysics, 68, 259.
11. Saleh, N. & Tornvall, P. (2007) Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis. Atherosclerosis, 195, 374.
12. Saleh, N., Svane, B., Jensen, J., Hansson, L.O., Nordin, M. & Tornvall, P. (2005) Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. American Heart Journal, 149, 876.
13. Shishido, T., Nozaki, N., Takahashi, H., Arimoto, T., Niizeki, T., Koyama, Y. et al. (2006) Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury. Biochemical and Biophysical Research Communications, 345, 1446.
14. Stewart, C.R., Stuart, L.M., Wilkinson, K., van Gils, J.M., Deng, J., Halle, A. et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunology, 11, 155.
15. Taganov, K.D., Boldin, M.P., Chang, K.J. & Baltimore, D. (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America, 103, 12481.
16. Versaci, F., Gaspardone, A., Tomai, F., Ribichini, F., Russo, P., Proietti, I. et al. (2002) Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). Journal of the American College of Cardiology, 40, 1935.
17. Xiong, X, Cho, M., Cai, X., Cheng, J, Jing, X., Cen, J et al. (2014) A common variant in premiR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, 761, 15.